Ayunan, Ansar B.
HRN: 24 30 78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/27/2023
01/02/2024
IV
4.5
Q6
Septicemia
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes